{'fraction_non_alphanumeric': 0.014466546112115732, 'fraction_numerical': 0.003616636528028933, 'mean_word_length': 4.831578947368421, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
RAC Confronts in Utero Gene Therapy Proposals

GENETIC DISEASESA National Institutes of Health advisory committee last week began what could be a long debate over whether to permit the next step in gene therapy: correcting genetic defects in a fetus before birth. Researchers say they may be ready to attempt such an experiment in 2 or 3 years, but fetal gene therapy carries potential new risks and ethical implications--including the possibility that transplanted genes could end up in sperm or egg (germ) cells and be passed on to future generations.